Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Freeline Therapeutics Holdings plc ADR buy Wedbush

Freeline Therapeutics Holdings plc ADR
Start price
€3.21
04.10.23 / 50%
Target price
€7.61
04.10.24
Performance (%)
0.00%
End price
-
05.10.24
Summary
This prediction is currently being closed. The BUY prediction by Wedbush is currently unchanged from the start price. Wedbush has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Freeline Therapeutics Holdings plc ADR - - -
iShares Core DAX® -1.283% 4.209% 7.084%
iShares Nasdaq 100 -3.338% -1.744% 26.177%
iShares Nikkei 225® -4.286% -1.621% 44.320%
iShares S&P 500 -2.311% -0.096% 20.823%

Comments by Wedbush for this prediction

In the thread Freeline Therapeutics Holdings plc ADR diskutieren
Prediction Buy
Perf. (%) 0.00%
Target price 7.606
Change
Ends at 04.10.24

Freeline Therapeutics Holdings plc (NASDAQ: FRLN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock, up previously from $5.00.
Ratings data for FRLN provided by MarketBeat

Wedbush 
0
Report Share
04.10.23
In the thread Trading Freeline Therapeutics Holdings plc ADR
Prediction Buy
Perf. (%) 0.00%
Target price 7.606
Change
Ends at 04.10.24

Die von Wedbush gewählte maximale Laufzeit wurde überschritten

Wedbush 
0
Report Share
05.10.24